Publication | Closed Access

MexAB-OprM-Specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: Discovery and early strategies for lead optimization

Early StrategiesAntimicrobial SusceptibilityHealth SciencesAntibioticsLead IdentificationPseudomonas AeruginosaAntibacterial AgentMicrobiologyAntimicrobial CompoundAntimicrobial ChemotherapyMedicineClinical MicrobiologyAntimicrobial ResistanceDrug DiscoveryLead OptimizationDrug Resistance